CION Ameerpet
Kidney Cancer · Diagnosis & Tests
Kidney cancer grade explained — Fuhrman and WHO/ISUP grades 1 to 4
Somewhere on your pathology report there is a short line that reads grade 1, grade 2, grade 3 or grade 4 — sometimes still labelled Fuhrman. That is the kidney cancer grade, and it describes one thing only: how abnormal the cells look under a microscope. It is not the size of the tumour, not how far it has travelled, and not a prediction about you. This page explains what a pathologist is actually looking at when the number is assigned, how the WHO/ISUP grade replaced the older Fuhrman grade for RCC, and why grade and stage answer two different questions.
- Grade is about appearance, not spread — It scores how far the cells have drifted from normal kidney cells. Where the cancer has reached is a separate question, answered by the stage.
- One feature decides grades 1 to 3 — In the WHO/ISUP system it comes down to how easily the nucleolus can be seen, and at what magnification. Grade 4 is kept for markedly abnormal cells.
- Not every kidney tumour is graded — The system was built for clear cell and papillary kidney cancer. Chromophobe tumours are not routinely graded with it, and benign tumours are not graded at all.
- Read by an oncologist, not alone — Biopsy, CT, MRI and blood work are delivered in-house at CION; kidney surgery, which is where most final grades come from, is coordinated with specialist urology and uro-oncology partners.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Where the number comes from
How a kidney cancer grade is actually decided
Grade is not measured by a machine and it is not read off a scan. It is a description written by a pathologist who has looked at your cells. Knowing what they were looking at makes the number far less frightening. Our kidney cancer guide covers diagnosis and treatment from the beginning; this page stays with one line of the report.
There has to be tissue first
A scan can show where a tumour is and how large it is, but it cannot grade it. Grading needs cells. They come either from a needle core biopsy, which is delivered in-house at CION alongside the CT, MRI and blood work, or from the tumour itself after it has been removed. Kidney surgery is coordinated for you with specialist urology and uro-oncology partners, where it may also be billed, and the specimen goes to pathology from there.
The tissue is cut, stained and read
Very thin sections are cut, mounted on slides and stained so that the internal structure of each cell becomes visible. The pathologist is not looking at the tumour as a lump at this point. They are looking at the nucleus of individual cells — its size, its outline, and one small structure inside it called the nucleolus, which is where the grading decision is made.
The nucleolus decides grades 1 to 3
The current WHO/ISUP system turns on a single, deliberately simple question: how easily can the nucleolus be seen, and at what magnification? If it is absent or barely visible even at high power, that is grade 1. If it is clear at high power but not at low power, grade 2. If it stands out at low power, grade 3. One feature, checked the same way by every pathologist, which is exactly the point.
The most abnormal area sets the grade
A tumour is not uniform. One region can look almost ordinary while another looks quite different, and the grade is taken from the most abnormal area seen — not from an average. That single rule explains most of the confusion patients meet later: a small biopsy sample can miss that area, so a grade given on a biopsy sometimes rises once the whole tumour is examined. It is more tissue giving a fuller answer, not a mistake.
Sarcomatoid and rhabdoid change is looked for separately
Some kidney cancers contain areas where the cells have lost their usual appearance altogether and look spindle-shaped or disorganised. These are described as sarcomatoid or rhabdoid features. When they are present, the tumour is grade 4 by definition, however the rest of it looks. They are reported as a separate line because they change the discussion about systemic treatment, not just the number.
The grade is read with everything else, by a tumour board
On its own the number decides nothing. It goes in front of medical, surgical and radiation oncologists together with the stage, the tumour type, the surgical margins and your kidney function, and the plan is built along NCCN lines from all of it. That is also where the grade is translated into plain language for you. The route from there is set out on our kidney cancer treatment in Hyderabad page. Book a free consultation if you would like your report read this way.
Grade and stage are not the same thing, and they are not ranked against each other.
Stage answers where: how large the tumour is and whether it has gone beyond the kidney. Grade answers how the cells look. A small tumour still confined to the kidney can carry a high grade, and a larger one can be low grade. Neither number outranks the other — they are read together, which is why a report shows both on separate lines.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
A grade is a description. Ask what it changes.
Our medical oncologists go through the pathology report with you, say what the grade means alongside your stage, and arrange a specialist re-read where the finding is borderline. Free first consultation, and no commitment to start treatment.
Grade 1 to grade 4
What each WHO/ISUP grade describes
Read this to understand the line on your report, not to grade your own tumour. The assignment is made by a pathologist looking at the whole slide set, and the boundary between two neighbouring grades is often a judgement call that a second read is worth having.
| Grade | What the pathologist sees | What it means in practice |
|---|---|---|
| Grade 1 | Nucleoli are absent, or so small and faint that they are hard to make out even at high magnification (around 400x). | The cells still look close to normal kidney cells. This is the least abnormal appearance on the scale, and such tumours generally behave in a slow, indolent way. |
| Grade 2 | Nucleoli are clearly visible at high magnification, but cannot be picked out when the slide is viewed at low power (around 100x). | Still towards the quiet end of the scale. Grade 1 and grade 2 are usually spoken of together as low grade. |
| Grade 3 | Nucleoli are prominent enough to be seen at low magnification, without switching to a higher-power lens. | An intermediate-to-high appearance. It does not mean the cancer has spread, but it is one of the findings that leads to closer follow-up. |
| Grade 4 | Marked variation in nuclear size and shape, cells with several nuclei, or areas of rhabdoid or sarcomatoid change. | The most abnormal appearance in the system. Sarcomatoid or rhabdoid features make a tumour grade 4 on their own, and are reported separately because they shape the systemic-treatment discussion. |
Notice that grades 1 to 3 all rest on one feature seen at two magnifications. That simplicity is deliberate: it was chosen so that two pathologists reading the same slide are more likely to arrive at the same number. What the grade then means for the years ahead is a separate subject, covered on how grade affects kidney cancer prognosis.
The fine print
Six things the grade line does not say out loud
These are the details that most often get missed when a report is handed over quickly. None of them are technicalities — each one changes how the number should be read.
Two systems
Fuhrman and WHO/ISUP are not rivals
Fuhrman came first and combined nuclear size, nuclear shape and nucleolar prominence into one score. In practice those three features did not always move together, and different pathologists graded the same slide differently. WHO/ISUP kept the 1-to-4 scale but reduced grades 1 to 3 to the single nucleolar question. Many Indian and international reports still print the word Fuhrman; the number is read the same way.
Not universal
Some kidney tumours are never graded
The system was designed and validated for clear cell and papillary renal cell carcinoma. Chromophobe renal cell carcinoma is not routinely graded with it, because its cells naturally look irregular in a way that would push every case into a high grade without meaning the same thing. Benign tumours such as oncocytoma and angiomyolipoma are not graded either, because they are not cancers.
Sampling
A biopsy grade can move
A core biopsy samples a narrow track through the tumour. Because grade is taken from the most abnormal area, a biopsy can under-call it if that area was not in the core. Pathologists often report a biopsy grade as low or high rather than as a single number for exactly this reason. If the tumour is later removed, the full specimen may give a different, usually higher, grade.
Automatic grade 4
Sarcomatoid features are recorded on their own line
Sarcomatoid or rhabdoid change means part of the tumour has lost its usual appearance entirely. It sets the grade at 4 regardless of what the rest of the slide shows, and it is written up separately rather than folded into the number. That matters because it is one of the findings that most influences whether systemic therapy is discussed, and how early.
In the plan
What the grade actually changes
Rarely the operation itself, which is driven mostly by the size and position of the tumour. More often it shapes how closely you are followed afterwards, and it is one of the inputs into the risk assessments used when disease is more advanced. The longer view is set out on how grade affects kidney cancer prognosis.
Second opinion
Borderline grades are worth a second read
The gap between grade 2 and grade 3 is one magnification setting. Where a report sits on that boundary, or where the grade does not seem to fit the rest of the picture, asking for the slides to be reviewed again is reasonable and routine. At CION a specialist re-read of your slides and report is arranged as part of a free second opinion, before any plan is settled.
Where the grade sits in the whole report. The grade is one line among several. Tumour type, size, whether the capsule or the renal vein is involved, the surgical margins and the presence of necrosis all sit beside it, and each is doing its own job. Our page on understanding your kidney cancer pathology report walks through the document as a whole, term by term. Once the report and the scans have been read together, the plan follows along NCCN lines, with systemic treatment and radiation delivered in-house by our medical oncology team and kidney surgery, ablation and PET-CT coordinated with specialist urology, uro-oncology and interventional radiology partners — the full route is on our kidney cancer treatment in Hyderabad page, with costs explained in writing before anything begins.
Take the first step
Bring the report to someone who will read all of it
Every case at CION goes to a tumour board, not one doctor's opinion. If a number on your report is being over-read, we will say so.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Questions people ask about kidney cancer grade
What does the grade of a kidney cancer mean?
Grade describes how abnormal the cancer cells look under a microscope, and it is a guide to how the tumour is likely to behave. A pathologist examines the tissue and scores it from 1 to 4. Grade 1 cells look close to normal kidney cells and tend to grow slowly. Grade 4 cells look markedly abnormal and tend to behave more aggressively. Grade says nothing about how large the tumour is or whether it has spread, because that is stage, and the two are decided separately. Your grade is one input into the plan alongside stage, tumour type and your kidney function. It is a description, not a verdict.
What is the difference between Fuhrman grade and WHO/ISUP grade?
They are two versions of the same idea. The Fuhrman system, in use since the 1980s, scored nuclear size, nuclear shape and nucleolar prominence together, which sounded precise but proved hard for different pathologists to apply the same way. The WHO/ISUP system replaced it and grades 1 to 3 on a single feature: how visible the nucleolus is, and at what magnification it becomes visible. Grade 4 is reserved for extreme nuclear abnormality, or for rhabdoid or sarcomatoid change. WHO/ISUP is the current standard, but many reports still carry the word Fuhrman out of habit. If yours does, read the number alongside the WHO/ISUP description rather than treating the two as unrelated.
Is grade the same as stage in kidney cancer?
No, and confusing the two causes a lot of unnecessary worry. Stage describes where the cancer is: how large the tumour is, whether it has grown beyond the kidney, and whether it has reached lymph nodes or other organs. It comes from your scans and from what the surgeon and pathologist find. Grade describes only how the cells look down a microscope. A small tumour still confined to the kidney can be high grade, and a larger tumour can be low grade. Both go into the same conversation, but they answer different questions, and your pathology report will state them on separate lines.
What does grade 3 kidney cancer mean?
It means the pathologist could see prominent nucleoli, the small dark bodies inside the cell nucleus, at a lower magnification than a grade 2 tumour would need. In practical terms it sits in the middle to upper part of the scale: more active than grade 1 or grade 2, less abnormal than grade 4. It does not mean the cancer has spread, and it does not decide your treatment on its own. Grade is read together with stage, tumour type and surgical margins, and what it changes most often is how closely you are followed afterwards. Our page on how grade affects kidney cancer prognosis goes into what that means over time.
Can a kidney biopsy give an accurate grade?
Often, but with a caveat worth knowing. A core biopsy takes a thin sample from one part of the tumour, and grade is assigned from the most abnormal area present, so a biopsy can under-call the grade if the needle did not reach that area. For this reason pathologists frequently report a biopsy grade as low or high rather than as a precise number. If the tumour is later removed, the whole specimen is examined and the grade can change, most often upwards. That is not an error; it is more tissue giving a fuller answer. Kidney biopsy and the imaging around it are delivered in-house at CION.
Are all kidney cancers given a grade?
No. The WHO/ISUP system was designed and validated for clear cell and papillary renal cell carcinoma, the commonest types. Chromophobe renal cell carcinoma is not routinely graded with it, because its cells look abnormal in a way that does not carry the same meaning. Several rarer subtypes are described in other terms, and benign kidney tumours such as oncocytoma and angiomyolipoma are not graded at all, because they are not cancers. So a report with no grade on it is usually correct rather than incomplete. It is still a fair thing to ask your oncologist to confirm when the report is explained to you.
This page is general health information about how kidney cancer is graded. It is not a diagnosis, and it cannot replace a specialist review of your own slides, scans and report. Only a doctor who has seen your pathology and examined you can say what your grade means for you. If you have a report you do not understand, please arrange a review rather than waiting — and tell your team straight away about new bone pain, breathlessness, unexplained weight loss or blood in the urine, because those symptoms change what is looked at next.